Serum Institute of India
PrivateLast Round
Grant
1/23/2024
Total Funding Raised
$585.9M
Company Overview
Serum Institute of India Pvt. Ltd. (SII) is an Indian multinational biotechnology and biopharmaceuticals company founded in 1966 by Dr. Cyrus Poonawalla. It is the world's largest vaccine manufacturer by the number of doses produced and sold globally, with more than 1.5 billion doses annually. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by the company. The company's mission was to make life-saving immuno-biologicals affordable and accessible, which were previously imported into India at high prices. Its product portfolio includes vaccines for polio, diphtheria, tetanus, pertussis, Hib, BCG, r-Hepatitis B, measles, mumps, rubella, and COVID-19. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization (WHO) and are used in national immunization programs in about 170 countries. Headquartered in Pune, India, the company is part of the privately-held Cyrus Poonawalla Group. In addition to its primary manufacturing operations, the company also makes strategic investments in other firms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Serum Institute of India Comps
Public and private peers based on sector, stage, and business model.
Serum Institute of India Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | 1/23/2024 | ||||
| Grant | 4/19/2021 | ||||
| Grant | 10/1/2020 | ||||
| Grant | 9/29/2020 | ||||
| Private Equity | 9/22/2015 | ||||
Grant | 11/1/2012 |
Serum Institute of India Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Government of India | Grant |
| Gavi, the Vaccine Alliance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Collaborating with Oxford University on malaria vaccine R78C.
- Apr 29, 2026
Collaborating with Oxford University on a new malaria vaccine, R78C.
Serum Institute of India Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Serum Institute of India's valuation, stock price, and market status.
